Table 3.
Effect of covariates on prevalence of ST131 in Escherichia coli (univariable random effects meta-regression models)
| p Value | |
|---|---|
| Study period (per month*) | 0.0011 |
| Infection or colonisation | 0.0002 |
| Colonisation | |
| Infection | |
| Outbreak setting | 0.9112 |
| Selection of isolates based on resistance pattern | <0.0001 |
| No selection on resistance profile | |
| ESBL/3GC-R | |
| CRE/CPE | |
| Other | |
| Study population | 0.6219 |
| Inpatients | |
| Outpatients/community | |
| Mixed | |
| Travellers | |
| Other/unknown | |
| Location | <0.0001 |
| Europe | |
| North America | |
| South America | |
| Australia | |
| Asia | |
| Africa | |
| Method used to detect ST131 | 0.3598 |
| MLST | |
| Extrapolation based on PFGE | |
| PCR | |
| Extrapolation based on PCR | |
| Other/unknown |
*Reference date: 1 January 2009.
CRE/CPE, carbapenem-resistant Enterobacteriaceae/carbapenemase-producing Enterobacteriaceae; ESBL/3GC-R, extended-spectrum β-lactamases/third-generation cephalosporin resistance; MLST, multi-locus sequence typing; PFGE. pulsed-field gel electrophoresis.